These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21994347)

  • 1. Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing.
    Schroen B; Heymans S
    Cardiovasc Res; 2012 Mar; 93(4):605-13. PubMed ID: 21994347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases.
    Szczepanska-Sadowska E; Cudnoch-Jedrzejewska A; Ufnal M; Zera T
    J Physiol Pharmacol; 2010 Oct; 61(5):509-21. PubMed ID: 21081794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
    Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
    Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease.
    Guarner V; Rubio-Ruiz ME
    Interdiscip Top Gerontol; 2015; 40():99-106. PubMed ID: 25341516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular diabetology: clinical, metabolic and inflammatory facets. Preface.
    Fisman EZ; Tenenbaum A
    Adv Cardiol; 2008; 45():xi-xiii. PubMed ID: 18409234
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
    Mavri A; Alessi MC; Juhan-Vague I
    J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome, diabetes and lung dysfunction.
    Tiengo A; Fadini GP; Avogaro A
    Diabetes Metab; 2008 Nov; 34(5):447-54. PubMed ID: 18829364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease.
    Haas MJ; Mooradian AD
    Diabetes Metab Res Rev; 2010 Feb; 26(2):90-9. PubMed ID: 20047197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis.
    Russell JC; Proctor SD
    Cardiovasc Pathol; 2006; 15(6):318-30. PubMed ID: 17113010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue inflammation in obesity and metabolic syndrome.
    Nishimura S; Manabe I; Nagai R
    Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; Leroith D; Karnieli E
    Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk.
    Gremese E; Ferraccioli G
    Autoimmun Rev; 2011 Aug; 10(10):582-9. PubMed ID: 21539940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in obesity and the metabolic syndrome.
    Heneghan HM; Miller N; Kerin MJ
    Obes Rev; 2010 May; 11(5):354-61. PubMed ID: 19793375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
    Müller A; Mulhall JP
    Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases.
    Yang Z; Ming XF
    Obes Rev; 2012 Dec; 13 Suppl 2():58-68. PubMed ID: 23107260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.